These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 18772386)
21. Translocation of the serine protease Omi/HtrA2 from mitochondria into the cytosol upon seizure-induced hippocampal injury in the neonatal rat brain. Rami A; Kim M; Niquet J Neurochem Res; 2010 Dec; 35(12):2199-207. PubMed ID: 21132459 [TBL] [Abstract][Full Text] [Related]
22. Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain. Zhang Y; Appleton BA; Wu P; Wiesmann C; Sidhu SS Protein Sci; 2007 Aug; 16(8):1738-50. PubMed ID: 17656586 [TBL] [Abstract][Full Text] [Related]
23. Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm. Liu Z; Li H; Derouet M; Berezkin A; Sasazuki T; Shirasawa S; Rosen K J Biol Chem; 2006 May; 281(21):14738-47. PubMed ID: 16461771 [TBL] [Abstract][Full Text] [Related]
24. MLF1 is a proapoptotic antagonist of HOP complex-mediated survival. Sun Y; Chao JR; Xu W; Pourpak A; Boyd K; Moshiach S; Qi GY; Fu A; Shao HR; Pounds S; Morris SW Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):719-727. PubMed ID: 28137643 [TBL] [Abstract][Full Text] [Related]
25. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. Trencia A; Fiory F; Maitan MA; Vito P; Barbagallo AP; Perfetti A; Miele C; Ungaro P; Oriente F; Cilenti L; Zervos AS; Formisano P; Beguinot F J Biol Chem; 2004 Nov; 279(45):46566-72. PubMed ID: 15328349 [TBL] [Abstract][Full Text] [Related]
26. The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal. Vande Walle L; Wirawan E; Lamkanfi M; Festjens N; Verspurten J; Saelens X; Vanden Berghe T; Vandenabeele P Cell Res; 2010 Apr; 20(4):421-33. PubMed ID: 20125124 [TBL] [Abstract][Full Text] [Related]
27. YAP Inhibits the Apoptosis and Migration of Human Rectal Cancer Cells via Suppression of JNK-Drp1-Mitochondrial Fission-HtrA2/Omi Pathways. Li H; He F; Zhao X; Zhang Y; Chu X; Hua C; Qu Y; Duan Y; Ming L Cell Physiol Biochem; 2017; 44(5):2073-2089. PubMed ID: 29241219 [TBL] [Abstract][Full Text] [Related]
28. The induction of reactive oxygen species and loss of mitochondrial Omi/HtrA2 is associated with S-nitrosoglutathione-induced apoptosis in human endothelial cells. Liu QB; Liu LL; Lu YM; Tao RR; Huang JY; Han F; Lou YJ Toxicol Appl Pharmacol; 2010 May; 244(3):374-84. PubMed ID: 20153346 [TBL] [Abstract][Full Text] [Related]
30. Mitochondrial Omi/HtrA2 Promotes Caspase Activation Through Cleavage of HAX-1 in Aging Heart. Liu X; Lei J; Wang K; Ma L; Liu D; Du Y; Wu Y; Zhang S; Wang W; Ma X; Liu H Rejuvenation Res; 2017 Jun; 20(3):183-192. PubMed ID: 27998213 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2. Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148 [TBL] [Abstract][Full Text] [Related]
32. Loss of high-temperature requirement protein A2 protease activity induces mitonuclear imbalance via differential regulation of mitochondrial biogenesis in sarcopenia. Zhou H; Yuan D; Gao W; Tian J; Sun H; Yu S; Wang J; Sun L IUBMB Life; 2020 Aug; 72(8):1659-1679. PubMed ID: 32353215 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. Cilenti L; Lee Y; Hess S; Srinivasula S; Park KM; Junqueira D; Davis H; Bonventre JV; Alnemri ES; Zervos AS J Biol Chem; 2003 Mar; 278(13):11489-94. PubMed ID: 12529364 [TBL] [Abstract][Full Text] [Related]
34. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. Park HJ; Kim SS; Seong YM; Kim KH; Goo HG; Yoon EJ; Min do S; Kang S; Rhim H J Biol Chem; 2006 Nov; 281(45):34277-87. PubMed ID: 16968707 [TBL] [Abstract][Full Text] [Related]
35. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease. Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400 [TBL] [Abstract][Full Text] [Related]
36. Hax1 lacks BH modules and is peripherally associated to heavy membranes: implications for Omi/HtrA2 and PARL activity in the regulation of mitochondrial stress and apoptosis. Jeyaraju DV; Cisbani G; De Brito OM; Koonin EV; Pellegrini L Cell Death Differ; 2009 Dec; 16(12):1622-9. PubMed ID: 19680265 [TBL] [Abstract][Full Text] [Related]
37. Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target. Bhuiyan MS; Fukunaga K Curr Drug Targets; 2009 Apr; 10(4):372-83. PubMed ID: 19355862 [TBL] [Abstract][Full Text] [Related]
38. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo. Yun J; Cao JH; Dodson MW; Clark IE; Kapahi P; Chowdhury RB; Guo M J Neurosci; 2008 Dec; 28(53):14500-10. PubMed ID: 19118185 [TBL] [Abstract][Full Text] [Related]